Hjem › Nyrekancer
Nyrekancer kliniske forsøg rekrutterer i USA
59 studier for Nyrekancer rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- New York City, NY15 studier
- Nashville, TN12 studier
- Boston, MA12 studier
- Houston, TX10 studier
- Washington, DC9 studier
- San Diego, CA9 studier
- St. Louis, MO9 studier
- Dallas, TX9 studier
- Edison, NJ8 studier
- Seattle, WA8 studier
- Jacksonville, FL7 studier
- Miami, FL7 studier
- Los Angeles, CA7 studier
- Rochester, MN7 studier
- Baltimore, MD7 studier
- Omaha, NE6 studier
- Durham, NC6 studier
- Mountain View, CA6 studier
- Aurora, CO6 studier
- Baldwin Park, CA6 studier
- Queens, NY6 studier
- Phoenix, AZ5 studier
- Cleveland, OH5 studier
- Pittsburgh, PA5 studier
- Columbus, OH5 studier
- New Rochelle, NY5 studier
- Staten Island, NY5 studier
- Portland, OR4 studier
- Atlanta, GA4 studier
- Louisville, KY4 studier
- New Haven, CT4 studier
- Highlands Ranch, CO4 studier
- Detroit, MI4 studier
- San Francisco, CA4 studier
- Denver, CO4 studier
- Orange, CA4 studier
- East Norwalk, CT4 studier
- San Antonio, TX4 studier
- Irvine, CA3 studier
- Waukegan, IL3 studier
Efter delstat
- Arizona8 studier
- Arkansas3 studier
- Californien19 studier
- Colorado9 studier
- Connecticut6 studier
- Florida14 studier
- Georgia6 studier
- Illinois7 studier
- Indiana4 studier
- Iowa4 studier
- Kentucky4 studier
- Louisiana3 studier
- Maryland16 studier
- Massachusetts14 studier
- Michigan6 studier
- Minnesota10 studier
- Missouri10 studier
- Nebraska6 studier
- New Jersey8 studier
- New York17 studier
- North Carolina8 studier
- Ohio10 studier
- Oklahoma4 studier
- Oregon4 studier
- Pennsylvania10 studier
- South Carolina5 studier
- Tennessee12 studier
- Texas18 studier
- Virginia6 studier
- Washington8 studier
- Wisconsin6 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT00050752Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07059884Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
4 Weeks · Alle køn · Opdateret 2. okt. 2026 · NCT01109394[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT06479811A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06234605Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT05287945Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT00026884Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07011719Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT00033137Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT04981119A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07401875NSAID Use After Robotic Partial Nephrectomy
RekruttererFase 2
Alder 18 til 99 · Alle køn · Opdateret 24. sep. 2026 · NCT05842044Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 18. sep. 2026 · NCT06948552Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 18. sep. 2026 · NCT07828704A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07688187Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07227415Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT06138067A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT05536141Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT00001238A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT07123090A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT07195682Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 3. aug. 2026 · NCT07300241Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 3. aug. 2026 · NCT05433142A Study of a Side Effects and Resource Navigation Program for People With Cancer
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT07646847Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
RekruttererFase 1/2
Alder 18 til 100 · Alle køn · Opdateret 29. jul. 2026 · NCT05665361Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.